Fingers were pointed at antibodies, widely used reagents to detect proteins in cells and tissues, with questions raised about their specificity and sensitivity. Pathologist, David Rimm ...

There are approximately 24 monoclonal antibody therapies on the US market at present, and approximately 240 more in various stages of clinical investigation. Nearly 30 were in Phase III trials as of ...

The conventional method is prone to failure because protein complexes are unstable during immunization, disrupting the process by which immune system cells react and generate antibodies ...

Sino Biological provides four major antibody development platforms and four major protein expression platforms, which enable engagement in early development projects of multispecific antibody ...

Once the final antibody is obtained, the DNA reveals the sequence of the encoded protein and provides an exact record of the antibody, which can be stored and replicated at will by molecular ...

Recent advances in biotechnology have fuelled the development of bispecific antibodies. However, there still remains a number of development challenges for those working in bioprocessing or cell line ...

Advancements in antibody technologies and protein data are driving new possibilities in cancer research, enabling the identification of novel biomarkers and enhancing therapeutic strategies. In this ...

Proteintech Group, the benchmark in antibodies, today announces an agreement to purchase HumanZyme. HumanZyme is a leading manufacturer of recombinant human proteins. Their proprietary human ...

Get Instant Summarized Text (Gist) Fusing two immune system proteins, BTLA and HVEM, enhances stability during immunization, enabling the generation of monoclonal antibodies. This method allows ...